These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10084381)

  • 1. Profiles of aprindine, cibenzoline, pilsicainide and pirmenol in the framework of the Sicilian Gambit. The Guideline Committee for Clinical Use of Antiarrhythmic Drugs in Japan (Working Group of Arrhythmias of the Japanese Society of Electrocardiology).
    Kodama I; Ogawa S; Inoue H; Kasanuki H; Kato T; Mitamura H; Hiraoka M; Sugimoto T
    Jpn Circ J; 1999 Jan; 63(1):1-12. PubMed ID: 10084381
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacokinetics and pharmacodynamics of class I antiarrhythmic agents after a single oral administration].
    Yokota M; Toyama J; Ukai M; Miyahara T; Koide M; Kato R; Yasui S; Sotobata I
    Jpn Circ J; 1992; 56 Suppl 5():1480-4. PubMed ID: 1291746
    [No Abstract]   [Full Text] [Related]  

  • 3. The Sicilian gambit. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Circulation; 1991 Oct; 84(4):1831-51. PubMed ID: 1717173
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The 'Sicilian Gambit'. A new approach to the classification of antiarrhythmic drugs based on their actions on arrhythmogenic mechanisms. The Task Force of the Working Group on Arrhythmias of the European Society of Cardiology.
    Eur Heart J; 1991 Oct; 12(10):1112-31. PubMed ID: 1723682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classifying antiarrhythmic actions: by facts or speculation.
    Vaughan Williams EM
    J Clin Pharmacol; 1992 Nov; 32(11):964-77. PubMed ID: 1474169
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiarrhythmic drugs.
    Hillis WS; Whiting B
    Br Med J (Clin Res Ed); 1983 Apr; 286(6374):1332-6. PubMed ID: 6132656
    [No Abstract]   [Full Text] [Related]  

  • 7. Antiarrhythmic drug classifications and the clinician: a gambit in the land of chaos.
    Katritsis D; Camm AJ
    Clin Cardiol; 1994 Mar; 17(3):142-8. PubMed ID: 7513270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of antiarrhythmic drugs on the hyperpolarization-activated cyclic nucleotide-gated channel current.
    Tamura A; Ogura T; Uemura H; Reien Y; Kishimoto T; Nagai T; Komuro I; Miyazaki M; Nakaya H
    J Pharmacol Sci; 2009 Jun; 110(2):150-9. PubMed ID: 19498275
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antiarrhythmic effect of aprindine on several types of ventricular arrhythmias.
    Ueda M; Kimoto S; Matsuda S; Kawakami M; Mroishige E; Matsumura S; Takeda H
    Jpn J Pharmacol; 1975 Oct; 25(5):549-61. PubMed ID: 1221137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Electrophysiological classification of newer antiarrhythmic drugs (author's transl)].
    Schmitz W
    Klin Wochenschr; 1980 Sep; 58(18):907-18. PubMed ID: 6110804
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Blockade of 2,4-dinitrophenol induced ATP sensitive potassium current in guinea pig ventricular myocytes by class I antiarrhythmic drugs.
    Wu B; Sato T; Kiyosue T; Arita M
    Cardiovasc Res; 1992 Nov; 26(11):1095-101. PubMed ID: 1291087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New anti-arrhythmia drugs].
    Vidal Garate J; Romero-Ayala LC; Cárdenas Loaeza M
    Arch Inst Cardiol Mex; 1983; 53(2):159-78. PubMed ID: 6411015
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Can antiarrhythmic agents be selected based on mechanism of action?
    Lau W; Newman D; Dorian P
    Drugs; 2000 Dec; 60(6):1315-28. PubMed ID: 11152014
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kinetics of frequency-dependent conduction delay by class I antiarrhythmic drugs in human atrium.
    Sakai R; Inoue D; Ishibashi K; Inoue M; Shirayama T; Yamahara Y; Asayama J; Nakagawa M
    J Cardiovasc Pharmacol; 1995 Jun; 25(6):953-60. PubMed ID: 7564341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electropharmacology of antiarrhythmic drugs.
    Rosen MR; Wit AL
    Am Heart J; 1983 Oct; 106(4 Pt 2):829-39. PubMed ID: 6412533
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antifibrillatory and profibrillatory actions of selected class I antiarrhythmic agents.
    Fagbemi SO; Chi L; Lucchesi BR
    J Cardiovasc Pharmacol; 1993 May; 21(5):709-19. PubMed ID: 7685439
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in antiarrhythmic therapy. The role of newer antiarrhythmic drugs.
    Nademanee K; Singh BN
    JAMA; 1982 Jan; 247(2):217-22. PubMed ID: 6796709
    [No Abstract]   [Full Text] [Related]  

  • 18. Negative Inotropic Effects of Class I Antiarrhythmics on Guinea Pig Ventricular Myocardium: Correlation with L-Type Ca
    Hiiro H; Hashimoto T; Mizoguchi M; Kaneko M; Deguchi N; Takahashi Y; Hamaguchi S; Namekata I; Tanaka H
    Biol Pharm Bull; 2023; 46(1):133-137. PubMed ID: 36596522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. QT-prolonging class I drug, disopyramide, does not aggravate but suppresses adrenaline-induced arrhythmias. Comparison with cibenzoline and pilsicainide.
    Miyamoto S; Zhu B; Teramatsu T; Aye NN; Hashimoto K
    Eur J Pharmacol; 2000 Jul; 400(2-3):263-9. PubMed ID: 10988343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antifibrillatory potency of aprindine, mexiletine, tocainide and lignocaine compared on Langendorff-perfused hearts of rabbits and guinea-pigs.
    Almotrefi AA; Baker JB
    J Pharm Pharmacol; 1980 Nov; 32(11):746-50. PubMed ID: 6110721
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.